Project Grant R61NS141760
Award Date 8/1/26
Completion Date 7/31/28
Dollars Obligated $723K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Aurora, CO 80045, USA
Similar Awards
- The National Institute of Neurological Disorders and Stroke, a component of the Department of Health and Human Services National Institutes of Health, awarded $575,655 to the Regents of the University of Colorado (doing business as University of Colorado-Denver) on June 16, 2026, under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853) for a Project Grant (R01NS143960). The award funds research investigating whether paired vagus nerve...
- The National Institute of Neurological Disorders and Stroke awarded The General Hospital Corporation (doing business as Massachusetts General Hospital) $511,402 on February 1, 2026, under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853) to develop non-invasive transcutaneous vagus nerve stimulation as a novel neuromodulatory intervention targeting aneurysmal subarachnoid hemorrhage. The project will test whether non-invasive vagus nerve...
- The National Institute of Neurological Disorders and Stroke awarded $422,125 to the University of Miami on September 1, 2026, under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853) to conduct a randomized, waitlist-controlled mechanistic trial characterizing how auricular vagus nerve stimulation modulates HIV-associated peripheral neuropathy in aging adults. The study enrolls 70 adults aged 50 and older with chronic HIV-associated...
- The National Institute of Mental Health awarded Evren Technologies, Inc. a $769,743 project grant under the Mental Health Research Grants program (CFDA 93.242) to develop a personalized transcutaneous vagal nerve stimulation device for post-traumatic stress disorder research and treatment. Evren will create the Phoenix Laboratory, the first non-invasive vagal nerve stimulator designed to meet the complex needs of both researchers and patients. In Phase I, Evren will develop the stimulator and...
- The National Institute of Neurological Disorders and Stroke awarded Vanderbilt University $394,915 on July 1, 2026, under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853) to investigate and augment cholinergic signaling for enhanced neuroprosthetic performance. The research targets mechanisms that accelerate learning and control of brain-computer interfaces (BCIs) for paralyzed patients. Current intracortical neuroprosthetic implants have...
- The National Institute of Neurological Disorders and Stroke (NINDS) awarded Massachusetts Eye and Ear Infirmary $452,713 on May 14, 2026, under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853) to investigate vasoactive intestinal peptide (VIP) signaling mechanisms in thalamocortical circuit plasticity and learning. The research will examine how VIP, expressed by cortical inhibitory interneurons, modulates circuit excitability and drives...
- The National Institute of Neurological Disorders and Stroke awarded The Regents of the University of Colorado (doing business as University of Colorado-Denver) $535,124 on June 16, 2026, under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853) to conduct research on neural circuits for disinhibition in the cerebellum. The funded work uses functional recordings, circuit-targeted activity manipulations, and behavioral analysis to determine how...
- The National Institute of Neurological Disorders and Stroke, part of the Department of Health and Human Services National Institutes of Health, awarded the University of Virginia $236,896 on February 1, 2026, under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853) to explore the link between enteric glial cells and multiple sclerosis etiology. The research investigates the hypothesis that enteric glial cells in the gastrointestinal tract may...
- The National Institute of Neurological Disorders and Stroke awarded $427,712 to The Regents of the University of Colorado (University of Colorado-Denver) on March 2, 2026, under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853) to develop and validate a language model approach for identifying B cell receptors associated with multiple sclerosis. The recipient will test the effectiveness of a machine-learning classifier in distinguishing...
- The National Institute of Neurological Disorders and Stroke awarded Washington University in St. Louis $493,332 on August 1, 2026, under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853) to develop a surface electroneurography device for in-office assessment of peripheral nerve recovery. Washington University partnered with Biocircuit Technologies to design a diagnostic system addressing limitations in current peripheral nerve injury...